We tested this within the paired tumor-normal cohort (n=1604 individuals), among the 25 individuals for whom the sole germline finding was a missense MSH2 variant (Fig. 5 and Additional file 3: Table S2). This evidence concerns the gene MSH2 and neoplasm.